EXELIXIS INC

About

Exelixis Inc. is a biotechnology company focused on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer. The company’s flagship product, CABOMETYX, is a leading medicine indicated for various forms of advanced kidney and liver cancer. By leveraging its expertise in biological processes, Exelixis aims to expand its oncology portfolio through internal research and strategic collaborations.